Back
Akero Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison
Sell
38
AKRO
Akero Therapeutics
Last Price:
$25.11
Seasonality Move:
-13.92%
Sell
48
BBIO
BridgeBio Pharma
Last Price:
$33.79
Seasonality Move:
-4.32%
Sell
38
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $25.14. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy, Sell or Hold?
-
The current BridgeBio Pharma [BBIO] share price is $33.79. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $25.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $33.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.68 | Sell |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | 466777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.87 - 29.69) | Sell |
Bollinger Bands (100): | (26.39 - 31.41) | Sell |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.91 | Buy |
Relative Strength Index (14 RSI): | 68.27 | Buy |
Chaikin Money Flow: | -2512401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.44 - 31.96) | Buy |
Bollinger Bands (100): | (24.1 - 29.32) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.2 | Buy |
20-day SMA: | 26.69 | Sell |
50-day SMA: | 29.44 | Sell |
200-day SMA: | 25.88 | Sell |
8-day EMA: | 24.51 | Buy |
20-day EMA: | 26.24 | Sell |
50-day EMA: | 28.03 | Sell |
200-day EMA: | 27.58 | Sell |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.45 | Buy |
20-day SMA: | 29.52 | Buy |
50-day SMA: | 27.49 | Buy |
200-day SMA: | 26.72 | Buy |
8-day EMA: | 32.71 | Buy |
20-day EMA: | 30.5 | Buy |
50-day EMA: | 28.38 | Buy |
200-day EMA: | 27.2 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and an increase next year of $0.23 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and an increase next year of $0.70 per share.
Akero Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |